Navigation Links
CDC Enters into Research Collaboration with Edico Genome to Evaluate Performance of DRAGEN Hardware Platform

SAN DIEGO, Oct. 9, 2015 /PRNewswire/ -- The Centers for Disease Control and Prevention, through the National Center for Emerging and Zoonotic Infectious Diseases, Office of Advanced Molecular Detection (OAMD), and Edico Genome have entered into a research collaboration to evaluate the performance of Edico Genome's DRAGEN hardware platform. The goal of this research collaboration is to evaluate the utility of the Edico Genome DRAGEN platform for public health and infectious disease applications. This collaboration will also focus on co-developing the databases, configurations and parameters to optimize the hardware platform for microbial applications.

With the advent of next-generation sequencing (NGS) and other high-throughput laboratory technologies, there is an increasing need for robust high-performance computing and bioinformatics capacity. CDC's OAMD is currently responsible for the CDC High Performance Computing Center of Excellence, which includes multiple Linux clusters, virtualization capacity and supports CDC laboratories and the broader public health user community for scientific computing and technical sequencing requirements.

Edico Genome recently announced the availability of DRAGEN, a custom coprocessor platform that uses field-programmable gate array (FPGA) to provide hardware-accelerated analysis of genomic sequence data. While this technology has primarily been applied to the analysis of human genomes to date, it has the potential to replace or supplement large computational clusters and/or cloud services that are currently used for microbial genomic and metagenomic analysis, resulting in faster, more actionable time-to-answer and cost savings.

About Edico Genome
Edico Genome, developer of the world's first next-generation sequencing Bio-IT processor, DRAGEN™, is helping usher in the new era of precision medicine by enabling customized treatments and data-driven insights tailored to the individual. At the heart of personalized medicine is next-generation sequencing (NGS), which is growing at an unprecedented pace. By increasing the speed and accuracy of NGS data analysis, such as whole genome sequencing, Edico Genome's computing platform makes it easier to discover links between DNA sequence variations and human disease, allowing clinicians and researchers to reveal answers more quickly. For more information, visit or follow @EdicoGenome.

Logo -


SOURCE Edico Genome
Copyright©2015 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Elbit Imaging Announces Its Subsidiary, Plaza Centers, Has Announced on an Acquisition of Loan to Control Liberec Plaza in the Czech Republic
2. Advanzeon Solutions, Inc.s Wholly-Owned Subsidiary Pharmacy Value Management Solutions, Inc., Signs Agreement with All Med Medical and Rehabilitation Centers
3. A Significant Number of Adults Cant Identify Signs of Substance Abuse in Seniors; According to a New National Survey by Harris Poll on behalf of Caron Treatment Centers
4. China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials
5. Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimers Disease And Migraine Programs
6. HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd.
7. Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus
8. Merus enters into 72.8 million euro series C financing led by Sofinnova Ventures and Novo A/S
9. Syndax Enters Clinical Trial Collaboration in Cancer Immunotherapy Combining Entinostat and Atezolizumab
10. Sequenom Enters Collaboration With UC San Diego Moores Cancer Center With Novel Liquid Biopsy Assay
11. CMC Biologics Enters into Agreement with the PATH Malaria Vaccine Initiative for Accelerated Development and Manufacturing of Monoclonal Antibodies
Post Your Comments:
(Date:8/27/2020)... ... ... The GHT Companies , a leading developer and distributor of nutraceutical products, ... with a press conference at its manufacturing facility in Vista. Here are the ... overall donation result exceeding $30,000 to Feeding San Diego, Who: Jim Rex, CEO, ...
(Date:8/26/2020)... ST. CHARLES, Mo. (PRWEB) , ... ... ... Bioanalytical Services, a member of Eurofins BioPharma Services, Laboratory Testing division, expands ... to the existing suite of Flow Cytometry platforms available. With industry-leading biomarker ...
(Date:8/26/2020)... ... August 26, 2020 , ... As the U.S. struggles in its 6th month ... the Coronavirus. Wear a mask, keep your distance, wash your hands. Prevention is the ... it best in 1977, “How much better it is to prevent disease than to ...
Breaking Medicine Technology:
(Date:9/1/2020)... (PRWEB) , ... September 01, 2020 , ... ... it has completed $3 million convertible note financing, which will be used to ... With the funds from this financing, the company will continue to expand its ...
(Date:8/31/2020)... ... August 31, 2020 , ... Cardiothoracic surgeons at Allegheny General ... Carnegie Mellon University (CMU) to develop a new heart monitoring device designed to ... surgery. , The AGH/CMU team was recently awarded a “Trailblazer” grant from the ...
(Date:8/31/2020)... ... ... Want to get moving, break up your routine, and make a difference ... launch its fourth annual STEPtember campaign in the United States to raise funds and ... are at this moment — encouraging people to move in the ways that work ...
(Date:8/31/2020)... ... ... economic outlook continues to put financial strain on many of us, so it just makes ... monthly expenses and put more into savings, if possible. , “That’s a great way to ... in place in case something were to happen to you,” says Lee Duncan, CMO & ...
(Date:8/31/2020)... ... August 31, 2020 , ... Bonde Innovations, ... patients with advanced heart failure, today announced that the company has been awarded ... $555,358 from the National Heart, Lung, and Blood Institute of the National Institutes ...
Breaking Medicine News(10 mins):